OTC Pharmaceuticals in Poland

Datamonitor's OTC Pharmaceuticals in Poland industry profile is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry. It includes data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

* Contains an executive summary and data on value, volume and/or segmentation

* Provides textual analysis of OTC Pharmaceuticals in Poland’s recent performance and future prospects

* Incorporates in-depth five forces competitive environment analysis and scorecards

* Includes a five-year forecast of OTC Pharmaceuticals in Poland

* The leading companies are profiled with supporting key financial metrics

* Supported by the key macroeconomic and demographic data affecting the market

Highlights

* Detailed information is included on market size, measured by both value and volume

* Five forces scorecards provide an accessible yet in depth view of the market’s competitive landscape

* Market shares are covered by manufacturer and/or brand

* Also features market breakdown by distribution channel

Why you should buy this report

* Spot future trends and developments

* Inform your business decisions

* Add weight to presentations and marketing materials

* Save time carrying out entry-level research

Market Definition

The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirinand other analgesics), and medicated skin products (anti-bacteria’s, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness).

For the purpose of this report Europe comprises Belgium, Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Romania, Russia, Spain, Sweden, Ukraine and the United Kingdom.

[Fade out the market survey infos]

TABLE OF CONTENTS
EXECUTIVE SUMMARY 2
MARKET OVERVIEW 7
Market definition 7
Research highlights 8
Market analysis 9
MARKET VALUE 10
MARKET SEGMENTATION I 11
MARKET SEGMENTATION II 12
MARKET SHARE 13
FIVE FORCES ANALYSIS 14
Summary 14
Buyer power 16
Supplier power 17
New entrants 18
Substitutes 20
Rivalry 21
LEADING COMPANIES 22
GlaxoSmithKline Plc 22
US Pharmacia 27
Herbapol Wroclaw SA 29
MARKET DISTRIBUTION 30
MARKET FORECASTS 31
Market value forecast 31
MACROECONOMIC INDICATORS 32
APPENDIX 34
Methodology 34
Industry associations 35
Related Datamonitor research 35
Disclaimer 37
ABOUT DATAMONITOR 38
Premium Reports 38
Summary Reports 38
Datamonitor consulting 38

LIST OF TABLES
Table 1: Poland OTC pharmaceuticals market value: $ million, 2005–09 10
Table 2: Poland OTC pharmaceuticals market segmentation I:% share, by value, 2009 11
Table 3: Poland OTC pharmaceuticals market segmentation II: % share, by value, 2009 12
Table 4: Poland OTC pharmaceuticals market share: % share, by value, 2009 13
Table 5: GlaxoSmithKline Plc: key facts 22
Table 6: GlaxoSmithKline Plc: key financials ($) 24
Table 7: GlaxoSmithKline Plc: key financials (£) 25
Table 8: GlaxoSmithKline Plc: key financial ratios 25
Table 9: US Pharmacia: key facts 27
Table 10: Herbapol Wroclaw SA: key facts 29
Table 11: Poland OTC pharmaceuticals market distribution: % share, by value, 2009 30
Table 12: Poland OTC pharmaceuticals market value forecast: $ million, 2009–14 31
Table 13: Poland size of population (million), 2005–09 32
Table 14: Poland gdp (constant 2000 prices, $ billion), 2005–09 32
Table 15: Poland gdp (current prices, $ billion), 2005–09 32
Table 16: Poland inflation, 2005–09 33
Table 17: Poland consumer price index (absolute), 2005–09 33
Table 18: Poland exchange rate, 2005–09 33

LIST OF FIGURES
Figure 1: Poland OTC pharmaceuticals market value: $ million, 2005–09 10
Figure 2: Poland OTC pharmaceuticals market segmentation I:% share, by value, 2009 11
Figure 3: Poland OTC pharmaceuticals market segmentation II: % share, by value, 2009 12
Figure 4: Poland OTC pharmaceuticals market share: % share, by value, 2009 13
Figure 5: Forces driving competition in the OTC pharmaceuticals market in Poland, 2009 14
Figure 6: Drivers of buyer power in the OTC pharmaceuticals market in Poland, 2009 16
Figure 7: Drivers of supplier power in the OTC pharmaceuticals market in Poland, 2009 17
Figure 8: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Poland, 2009 18
Figure 9: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Poland, 2009 20
Figure 10: Drivers of degree of rivalry in the OTC pharmaceuticals market in Poland, 2009 21
Figure 11: GlaxoSmithKline Plc: revenues & profitability 26
Figure 12: GlaxoSmithKline Plc: assets & liabilities 26
Figure 13: Poland OTC pharmaceuticals market distribution: % share, by value, 2009 30
Figure 14: Poland OTC pharmaceuticals market value forecast: $ million, 2009–14 31


[Fade out table of contents]